Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
29.83
-0.26 (-0.86%)
May 18, 2026, 4:00 PM EDT - Market closed

HRMY Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,7272,1601,9661,8343,2852,508
Market Cap Growth
-0.75%9.85%7.24%-44.18%30.96%21.96%
Enterprise Value
1,2511,5281,6621,6593,1512,464
Last Close Price
29.8337.4234.4132.3055.1042.64
PE Ratio
12.0313.8113.7115.1618.5573.52
Forward PE
8.0910.0511.8211.1423.0125.27
PEG Ratio
0.390.390.470.73--
PS Ratio
1.922.492.753.157.508.21
PB Ratio
1.902.482.983.938.1513.45
P/TBV Ratio
1.922.523.024.188.3613.54
P/FCF Ratio
5.056.218.998.3722.7625.53
P/OCF Ratio
5.056.208.958.3622.7425.45
EV/Sales Ratio
1.391.762.332.857.208.07
EV/EBITDA Ratio
5.826.547.737.6721.9523.16
EV/EBIT Ratio
6.607.338.718.6426.2228.15
EV/FCF Ratio
3.664.397.607.5721.8425.08
Debt / Equity Ratio
0.150.170.250.380.471.02
Debt / EBITDA Ratio
0.740.700.830.901.341.81
Debt / FCF Ratio
0.470.470.820.881.331.95
Net Debt / Equity Ratio
-0.53-0.70-0.44-0.34-0.33-0.23
Net Debt / EBITDA Ratio
-2.24-2.62-1.34-0.74-0.92-0.40
Net Debt / FCF Ratio
-1.41-1.76-1.32-0.73-0.91-0.43
Asset Turnover
0.710.760.790.780.790.71
Inventory Turnover
39.6431.6024.9725.1019.1313.45
Quick Ratio
3.453.463.142.614.795.01
Current Ratio
3.583.603.312.755.075.29
Return on Equity (ROE)
16.36%20.75%25.84%29.63%61.58%24.39%
Return on Assets (ROA)
10.98%13.55%15.99%19.21%37.63%18.80%
Return on Invested Capital (ROIC)
39.09%47.48%41.60%48.17%98.22%75.99%
Return on Capital Employed (ROCE)
18.28%22.62%25.93%30.91%24.66%26.04%
Earnings Yield
8.43%7.24%7.29%6.59%5.39%1.36%
FCF Yield
19.79%16.11%11.12%11.95%4.39%3.92%
Buyback Yield / Dilution
-0.87%-1.17%4.15%1.19%-3.20%-119.09%
Total Shareholder Return
-0.87%-1.17%4.15%1.19%-3.20%-119.09%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q